safety of using E. faecium as a food supplement. In a recent study of the ecological effects of the fermented milk product Gaio on the normal microflora of healthy Danish and Swedish volunteers who were or were not receiving simultaneous administration of vancomycin, no emergence of or increase in the number of vancomycin-resistant enterococci could be detected in any of the 40 volunteers after 10 days of intake. However, none of the Swedish volunteers and only 1 of the Danish volunteers harbored detectable levels of vancomycin-resistant enterococci when they entered the study [10] . The possibility that the probiotic strain can acquire transferable vancomycin resistance has yet to be elucidated.
In the present study, an in vitro conjugation assay done by use of a filter paper mating method was performed according to the method described by Murray and Hodel-Christian [11] . The recipient strain was the probiotic strain of E. faecium from the aforementioned Gaio product with induced resistance to streptomycin and rifampicin (strep r rif r ). Two different vanApositive E. faecium strains, type strain CCUG 36804 (Culture Collection, University of Göteborg, Sweden) and clinical strain SMI 141 (isolated in 1995 at the Swedish Institute for Infectious Disease Control, Stockholm, Sweden), were used as donor strains. Filters were incubated on blood agar plates at 37ЊC for 24 h. Recipient, donor, and transconjugant strains were isolated quantitatively on selective agar media that contained the appropriate antimicrobial agents.
Both donor strains transferred the vanA gene cluster to the recipient strain during the conjugation assay. The rates of conjugation were Ϫ6 cfu per recipient, for CCUG 36804, and 4.0 ϫ 10 Ϫ5 cfu per recipient for SMI 141. The conjugation event 1.8 ϫ 10 was confirmed by PCR, as were the species type and vanA carriage status of the donors, by use of E. faecium-specific primers and vanA gene-specific primers [12] , as shown in figure 1 . The recipient, donor, and transconjugant strains were further characterized by means of pulsed-field gel electrophoresis. This analysis showed that the parent probiotic strain (E. faecium), the recipient strain (E. faecium strep r rif r ), and the transconjugant strains had identical DNA banding patterns and that this differed markedly from the pulsed-field gel electrophoresis patterns of the donor strains, indicating true conjugation events ( figure 2) .
The results of the present study address the issue of the possible health risk of eating foods that contain enterococci. Previous studies have shown that transfer of vanA genes is possible in the gastrointestinal tracts of germ-free mice [13] . The authors of a study of gene transfer in the avian gastrointestinal tract, claim that in vitro methods, such as forced filter mating and liquid mating, underestimate the in vivo rates of gene transfer [14] . Furthermore, E. faecium has experimentally been shown to have a high colonization potential, especially if administered in connection with treatment with antimicrobial agents [15] . Therefore, intake of high concentrations of viable E. faecium, which may act as a potential recipient of glycopeptide resistance genes, by patients with antibiotic-induced disturbances of the microflora might facilitate dissemination and proliferation of resistance genes.
In conclusion, the probiotic E. faecium strain is a possible recipient of the vanA gene cluster under in vitro conditions. Therefore, the risk for in vivo conjugation cannot be ruled out and should be considered in evaluations of the safety of enterococcal probiotics.
